AHA 2019: Results from the Phase 3 ORION-10 Trial

Published: 07 Dec 2019

  • Views:

    Views Icon 171
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating

Prof R Scott Wright (Mayo Clinic, Rochester, MN, US) discuss Safety and Efficacy of Inclisiran in Patients With ASCVD and Elevated LDL Cholesterol at AHA 2019.

Filmed on site at AHA 2019 by Radcliffe Cardiology.</p>